Shingrix is set to launch in South Africa, promising better shingles protection. Find out what this means for patients and costs.
Shingrix launch in South Africa Raises Access Concerns
Original Article by Marcus Low & Catherine Tomlinson | Spotlight | 25 June 2026
Shingrix is set to launch in South Africa, promising better shingles protection. Find out what this means for patients and costs.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...